Portal de Periódicos da CAPES

Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia

2024; Lippincott Williams & Wilkins; Volume: 102; Issue: 4 Linguagem: Inglês

10.1212/wnl.0000000000208091

1526-632X

Cynthia Comella, Joseph Jankovic, Robert A. Hauser, Atul T. Patel, Marta Banach, Edvard Ehler, Domenico Vitarella, Roman G. Rubio, Todd M. Gross, Philipp Albrecht, Richard L. Barbano, Norman Bettle, Sylvia Bösch, Françoise Bouhour, James Boyd, Giovanni Castelnovo, Pratap Chand, Christine Cooper, Susan R. Criswell, Khashayar Dashtipour, Andres Deik, Aaron Ellenbogen, Virgilio Gerald H. Evidente, Danielle Feigenbaum, Susan H. Fox, Karen Frei, Jeffrey Gitt, John L. Goudreau, Behzad Habibi, Timothy Harrower, Bernhard Haslinger, Peter Hedera, Daragh Heitzman, Neal Hermanowicz, Jorge Hernández‐Vara, David Isaacs, Stuart Isaacson, Robert Jech, Hyder A. Jinnah, Christopher Kobylecki, Katja Kollewe, Katie Kompoliti, Dariusz Koziorowski, Alexandre Kreisler, Rajeev Kumar, Andreas Kupsch, Mark S. LeDoux, Peter A. LeWitt, Ebba Lohmann, Lydia López Manzanares, Irene A. Malaty, Janice M. Massey, Peter McAllister, Peter Moore, Elena Moro, William G. Ondo, Javier Pagonabarraga Mora, Sebastian Paus, Elizabeth Peckham, Rekha Pillai, Monika Rudzińska, Harvey Schwartz, Carlos Singer, Jarosław Sławek, Thomas Sycha, Dariusz A Szabela, Jessica Tate, N. Thakur, D. F. Torres, José M. Trejo, Daniel Truong, Winona Tse, Andrzej Tutaj, Alberto Vasquez, Oldřich Vyšata, Ivana Woznicová, Sharon Yegiaian,

Pain Mechanisms and Treatments

ASPEN-1 was a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy, duration of response, and safety of 2 doses of DaxibotulinumtoxinA for Injection (DAXI), a novel botulinum toxin type A formulation in participants with cervical dystonia (CD).